AstraZeneca PLC (AZN)
NASDAQ: AZN · IEX Real-Time Price · USD
68.55
+0.19 (0.28%)
At close: Apr 19, 2024, 4:00 PM
68.51
-0.04 (-0.06%)
After-hours: Apr 19, 2024, 7:44 PM EDT

AstraZeneca Revenue

In the year 2023, AstraZeneca had annual revenue of $45.81B with 3.29% growth. Revenue in the quarter ending December 31, 2023 was $12.02B with 7.28% year-over-year growth.

Revenue (ttm)
$45.81B
Revenue Growth
+3.29%
P/S Ratio
4.64
Revenue / Employee
$509,577
Employees
89,900
Market Cap
212.49B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202345.81B1.46B3.29%
Dec 31, 202244.35B6.93B18.53%
Dec 31, 202137.42B10.80B40.58%
Dec 31, 202026.62B2.23B9.16%
Dec 31, 201924.38B2.29B10.38%
Dec 31, 201822.09B-375.00M-1.67%
Dec 31, 201722.47B-537.00M-2.33%
Dec 31, 201623.00B-1.71B-6.90%
Dec 31, 201524.71B-1.84B-6.93%
Dec 31, 201426.55B741.00M2.87%
Dec 31, 201325.81B-2.17B-7.75%
Dec 31, 201227.97B-5.62B-16.72%
Dec 31, 201133.59B322.00M0.97%
Dec 31, 201033.27B465.00M1.42%
Dec 31, 200932.80B1.20B3.81%
Dec 31, 200831.60B2.04B6.91%
Dec 31, 200729.56B3.08B11.65%
Dec 31, 200626.48B2.53B10.54%
Dec 31, 200523.95B2.52B11.78%
Dec 31, 200421.43B2.58B13.67%
Dec 31, 200318.85B1.01B5.65%
Dec 31, 200217.84B--
Dec 31, 2001---
Dec 31, 2000---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.